EUVIMEDEUVIMED entdecken
Multizentrische Studie

Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension

Pierre Bigot iD, Jean-Christophe Bernhard, Zine-Eddine Khene iD, Charles Dariane, Souhil Lebdai, Nicolas Doumerc, François Xavier Nouhaud, Idir Ouzaid, Patrick Saulnier, Arnaud Méjean, Morgan Roupret, Karim Bensalah und 1 weitere

BJU International · 2023

DOI: 10.1111/bju.16124 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJU International, 2023. Verfasst von Pierre Bigot und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Angers University Hospital, Angers, France. Hauptthemen laut MEDLINE: Kidney Neoplasms, Nephrectomy, Hypertension. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Association Française d'Urologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate prospectively the effects of surgical excision of renal tumours on blood pressure (BP). Patients and Methods In a multicentre prospective study, we evaluated 200 patients who underwent nephrectomy for renal tumour between 2018 and 2020 at seven departments of the French Network for Kidney Cancer, the UroCCR. All patients had localized cancer without pre‐existing hypertension (HTN). Blood pressure was measured the week before nephrectomy, and at 1 month and 6 months after nephrectomy, according to the recommendations for home BP monitoring. Plasma renin was measured 1 week before surgery and 6 months after surgery. The primary endpoint was the occurrence of de novo HTN. The secondary endpoint was clinically significant increase in BP at 6 months, defined by an increase in systolic and/or diastolic ambulatory BP ≥10 mmHg or requirement for medical antihypertensive treatment.

Results

Blood pressure and renin measurements were available for 182 (91%) and 136 patients (68%), respectively. We excluded from the analysis 18 patients who had undeclared HTN detected on preoperative measurements. At 6 months, 31 patients (19.2%) had de novo HTN and 43 patients (26.3%) had a significant increase in their BP. Type of surgery was not associated with an increased risk of HTN (21.7% partial nephrectomy [PN] vs 15.7% radical nephrectomy [RN]; P = 0.59). There was no difference between plasmatic renin levels before and after surgery (18.5 vs 16; P = 0.46). In multivariable analysis, age (odds ratio [OR] 1.07, 95% confidence interval [CI] 1.02–1.12; P = 0.03) and body mass index (OR 1.14, 95% CI 1.03–1.26; P = 0.01) were the only predictors of de novo HTN.

Conclusion

Surgical treatment of renal tumours is associated with significant changes in BP, with de novo HTN occurring in almost 20% of the patients. These changes are not impacted by the type of surgery (PN vs RN). Patients who are scheduled to undergo kidney cancer surgery should be informed of these findings and have their BP closely monitored after the operation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsNephrectomyHypertensionHumansMaleFemaleMiddle AgedProspective StudiesAgedReninRisk FactorsBlood Pressure

Stichwörter der Autor:innen

blood pressurehypertensionpartial nephrectomyradical nephrectomyrenal cancerreninsurgery

Substanzen

Renin

Autor:innen und Institutionen

  • Department of Urology, Angers University Hospital, Angers, France.
  • Department of Urology, Bordeaux University Hospital, Bordeaux, France.
  • Department of Urology, Rennes University Hospital, Rennes, France.
  • Department of Urology, Hôpital Européen Georges-Pompidou, Paris, France.
  • Department of Urology, CHU de Toulouse, Toulouse, France.
  • Department of Urology, Rouen University Hospital, Rouen, France.

ORCID-Profile: Pierre Bigot, Zine-Eddine Khene

Förderung

  • Association Française d'Urologie

Zitieren

APA

Bigot, P., Bernhard, J. C., Khene, Z. E., Dariane, C., Lebdai, S., Doumerc, N., Nouhaud, F. X., Ouzaid, I., Saulnier, P., Méjean, A., Roupret, M., Bensalah, K., & French Committee of Urologic Oncology (2023). Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension. BJU International. https://doi.org/10.1111/bju.16124

Vancouver

Bigot P, Bernhard JC, Khene ZE, Dariane C, Lebdai S, Doumerc N, et al. Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension. BJU International. 2023. doi:10.1111/bju.16124

BibTeX
@article{Bigot2023,
  author = {Bigot, Pierre and Bernhard, Jean-Christophe and Khene, Zine-Eddine and Dariane, Charles and Lebdai, Souhil and Doumerc, Nicolas and Nouhaud, François Xavier and Ouzaid, Idir and Saulnier, Patrick and Méjean, Arnaud and Roupret, Morgan and Bensalah, Karim and French Committee of Urologic Oncology, French Committee of Urologic Oncology},
  title = {Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension},
  journal = {BJU International},
  year = {2023},
  doi = {10.1111/bju.16124}
}
Kostenlos starten →